Liver Metastasis Recruiting Phase 3 Trials for Icosapent ethyl (DB08887)

IndicationStatusPhase
DBCOND0029622 (Liver Metastasis)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03428477EPA for Metastasis Trial 2Prevention